Aclidinium bromide/formoterol in COPD: Added benefit for certain patient groups

12 mayo 2015

Patients with COPD grade III with no more than one flare-up per year and grade II patients benefit from the new aclidinium Bromide/formoterol drug combination, researchers note.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/BlR8cs3RxDI/150512103819.htm